Can a new drug combo stop vivax malaria from coming back?
NCT ID NCT07060794
First seen Apr 07, 2026 · Last updated May 24, 2026 · Updated 6 times
Summary
This study looks at whether a drug called tafenoquine can be safely combined with two common malaria treatments (DHA-piperaquine or artesunate-pyronaridine) in adults with vivax malaria. The goal is to see if these combinations work better at preventing the malaria from returning. About 507 adults will take part and be followed for six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIVAX MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.